How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review

BACKGROUND: Patients with severe vasodilation accompanied by refractory hypotension despite high doses of vasopressors were associated with a high mortality rate. The Ang-2 for the Treatment of High-Output Shock (ATHOS) 3 trial demonstrated that angiotensin 2 (Ang-2) could effectively increase MAP a...

Descripción completa

Detalles Bibliográficos
Autores principales: Semedi, Bambang Pujo, Rehatta, Nancy Margarita, Soetjipto, Soetjipto, Nugraha, Jusak, Mahyuddin, Muhammad H, Arnindita, Jannatin N, Wairooy, Nabilah A P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830054/
https://www.ncbi.nlm.nih.gov/pubmed/36636460
http://dx.doi.org/10.2147/OAEM.S391167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830054/
https://www.ncbi.nlm.nih.gov/pubmed/36636460
http://dx.doi.org/10.2147/OAEM.S391167

Ejemplares similares